ASMS 2019 is wrapping up in in Atlanta, GA, but it’s never too late to explore the new Thermo Scientific HR Multi-Attribute Method workflow. With the launch of a new comprehensive and verified high-resolution mass spectrometry-based workflow, biopharmaceutical scientists are no longer restricted by the complex series of assays typically required for the characterization and quality control of protein therapeutics.
The Thermo Scientific HR Multi-Attribute Method (MAM) meets the demand for a single, high-resolution mass spectrometry-based workflow designed to directly assess the product quality attributes of increasingly complex biotherapeutics. The workflow may replace the complicated sequence of lower-resolution methods that have previously prolonged characterization timelines. Supported by the Thermo Scientific Chromeleon Chromatography Data System (CDS) software, the HR MAM method simplifies and standardizes biotherapeutic characterization throughout the product pipeline, facilitating the transition of new drugs from initial research to development and manufacture.
The HR MAM provides biopharmaceutical scientists with:
A supported, comprehensive workflow from sample analysis to data processing, including new peak detection.